Chemours president Martinko buys $30,008 in company stock

Joseph T. Martinko, the President of Thermal & Specialized Solutions at The Chemours Company, acquired 1,939.8014 shares of the company's common stock on August 7, 2026. The purchase was disclosed in a Form 4 filing with the Securities and Exchange Commission, with each share costing $15.47, totaling $30,008. The stock's current price is $15.85, with a market capitalization of $2.3 billion.

Chemours' stock has fallen approximately 22% over the past six months. After the acquisition, Martinko now owns a total of 55,431.4012 shares of Chemours common stock, which includes directly owned shares, restricted stock units, and dividend equivalent units. According to InvestingPro analysis, Chemours is currently trading above its Fair Value, although analysts anticipate the company will become profitable this year.

Despite these sentiments, UBS recently downgraded Chemours from a Buy rating to Neutral, reducing its price target from $29.00 to $18.00. This downgrade is primarily due to uncertainties surrounding the earnings potential of the company's refrigerant business, known as TSS, which has been experiencing larger destocking and potential market share loss anticipated in 2026.